Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The RNA-induced silencing complex (RISC) is a multiprotein ribonucleoprotein assembly central to the RNA interference (RNAi) pathway in eukaryotic cells[1][3][4][6]. At its core, RISC is composed of an Argonaute protein bound to a small regulatory RNA, such as a microRNA (miRNA) or small interfering RNA (siRNA). After loading, RISC uses the guide RNA to target complementary messenger RNA (mRNA) transcripts through Watson-Crick base pairing, resulting in gene silencing by either degrading the target mRNA or preventing its translation[1][3][4][5]. RISC also participates in transcriptional gene silencing by promoting heterochromatin formation at specific genomic loci. RISC and its family members are pivotal in regulating cellular processes like proliferation, differentiation, apoptosis, antiviral immunity, and development. Aberrant activity or overexpression of RISC components is closely linked to various cancers, making it a promising target for RNA-based therapies. Key challenges include specificity, delivery, and avoidance of undesired molecular or immune effects[1][3][5][6].
Sequence-specific mRNA degradation (when loaded with siRNA); Sequence-specific translational inhibition (when loaded with miRNA); Epigenetic silencing via chromatin modulation (when part of RITS complex)
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA-induced silencing complex (RISC).